|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Non-current assets: | |||||||||
| Property, plant and equipment | |||||||||
| Intangible assets | |||||||||
| Goodwill | |||||||||
| Digital assets, pledged as collateral for convertible debt | |||||||||
| Digital assets, unrestricted | |||||||||
| Deposits and other receivables | |||||||||
| Prepaid expenses | |||||||||
| Other non-current financial assets | |||||||||
| Total non-current assets | |||||||||
| Current assets: | |||||||||
| Inventories | |||||||||
| Trade receivables | |||||||||
| Contract assets | |||||||||
| Prepaid expenses | |||||||||
| Other receivables | |||||||||
| Research tax credit receivable | |||||||||
| Short-term deposits | |||||||||
| Cash and cash equivalents | |||||||||
| Total current assets | |||||||||
| Total assets | |||||||||
| EQUITY (DEFICIT) AND LIABILITIES | |||||||||
| Equity (deficit): | |||||||||
| Issued capital, euro 0.01 nominal value, 1,599,589,702 ordinary shares issued and outstanding at December 31, 2025 (251,408,922 at December 31, 2024 and 246,262,004 at December 31, 2023) | |||||||||
| Share premium | |||||||||
| Other capital reserves | |||||||||
| Treasury shares | |||||||||
| Accumulated deficit | |||||||||
| Total accumulated deficit | |||||||||
| Other components of equity | |||||||||
| Total other components of equity | |||||||||
| Total equity (deficit) | |||||||||
| Non-current liabilities: | |||||||||
| Government loans | |||||||||
| Government research financing | |||||||||
| Convertible debt | |||||||||
| Interest-bearing receivables financing | |||||||||
| Convertible debt | |||||||||
| Convertible debt embedded derivative | |||||||||
| Lease liabilities | |||||||||
| Provisions | |||||||||
| Total provisions | |||||||||
| Trade payables and other non-current liabilities | |||||||||
| Deferred tax liabilities | |||||||||
| Contract liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Current liabilities: | |||||||||
| Trade payables | |||||||||
| Interest-bearing financing of receivables | |||||||||
| Interest-bearing receivables financing | |||||||||
| Convertible debt | |||||||||
| Total interest-bearing financing of receivables | |||||||||
| Convertible debt | |||||||||
| Convertible debt embedded derivative | |||||||||
| Convertible debt | |||||||||
| Total convertible debt embedded derivative | |||||||||
| Lease liabilities | |||||||||
| Unsecured related party loan | |||||||||
| Government loans | |||||||||
| Government research financing | |||||||||
| Other current liabilities and provisions | |||||||||
| Income tax liabilities of the parent company | |||||||||
| Contract liabilities | |||||||||
| Provisions | |||||||||
| Total provisions | |||||||||
| Total current liabilities | |||||||||
| Equity and liabilities | |||||||||
| Total equity and liabilities | |||||||||
Loading...
